FDA.reportPublic FDA data

caffeine / salicylamide / salicylic acid

RxCUI
1007853
RxNorm name
caffeine / salicylamide / salicylic acid
Term type
MIN
Status
Active
Updated
2026-10-29 05:59:11

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
caffeine1886
salicylamide9518
salicylic acid9525

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRcaffeine / salicylamide / salicylic acid1NAMES
RxNorm Namecaffeine / salicylamide / salicylic acid1NAMES
TTYMIN1ATTRIBUTES
RxCUI10078531CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01BCAntiinflammatory agents, non-steroidsATC1-4salicylic acid
ATCD01AEOther antifungals for topical useATC1-4salicylic acid
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN02BASalicylic acid and derivativesATC1-4salicylamide
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD012457SalicylamidesCHEMhas_ingredientsalicylamide
MEDRTD020156Salicylic AcidCHEMhas_ingredientsalicylic acid
MEDRTD000152Acne VulgarisDISEASEmay_treatsalicylic acid
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylamide
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylic acid
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_treatsalicylamide
MEDRTD017492Keratosis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD010146PainDISEASEmay_treatsalicylamide
MEDRTD011565PsoriasisDISEASEmay_treatsalicylic acid
MEDRTD012536Scalp DermatosesDISEASEmay_treatsalicylic acid
MEDRTD014860WartsDISEASEmay_treatsalicylic acid
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moasalicylamide
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moasalicylic acid
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008832Decreased Platelet AggregationPEhas_pesalicylamide
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pesalicylamide
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000009974Increased Skin KeratinizationPEhas_pesalicylic acid

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI